Systematic Financial Management LP Enanta Pharmaceuticals Inc Transaction History

Systematic Financial Management LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 12, 2020	SELL	$43.36 - $53.53 $276,636 - $341,521	-6,380 Closed	0 $0
Q2 2020 Aug 13, 2020	BUY	$46.37 - $57.58 $295,840 - $367,360	6,380 New	6,380 $320,000
Q1 2020 May 12, 2020	SELL	$40.22 - $62.0 $393,552 - $606,670	-9,785 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$57.95 - $66.61 $124,882 - $143,544	2,155 Added 28.24%	9,785 $605,000
Q3 2019 Nov 06, 2019	SELL	$60.08 - $88.17 $118,658 - $174,135	-1,975 Reduced 20.56%	7,630 $458,000
Q2 2019 Jul 26, 2019	BUY	$81.3 - $97.35 $780,886 - $935,046	9,605 New	9,605 $810,000

108

21.1M

4.8K

4.6K

Ticker ENTA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 20,724,900
Market Cap $109M
Description
Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases. Its research and development disease targets include respiratory syncytial virus, SARS-CoV-2, human metapneumovirus, and hepatitis B virus. The company has a collaborative development and li...

Get notified when there are updates to the investment portfolio of Systematic Financial Management LP, based on Form 13F filings with the SEC.

Stay updated on Systematic Financial Management LP with notifications on news.